ERBB2 and breast cancer: The erbB2 expression was detected to be increased in 20–30% of human BCs ErbB2 (HER2) positive BC strongly related to poor prognosis that result in emerging metastases nature of cancer and intrinsic resistance to endocrine and routine chemotherapy [266, 267].